177P Low HER2 expression does not influence prognosis in metastatic triple-negative breast cancer: Results from an international, multicenter analysis coordinated by the Austrian Group Medical Tumor Therapy (AGMT)
Title:
177P Low HER2 expression does not influence prognosis in metastatic triple-negative breast cancer: Results from an international, multicenter analysis coordinated by the Austrian Group Medical Tumor Therapy (AGMT)
Author:
Gampenrieder, S.P. Dezentjé, V. Lambertini, M. de Nonneville, A. Marhold, M. Le Du, F. Saavedra Serrano, C. Alpuim Costa, D. Blondeaux, E. Del Mastro, L. Bertucci, F. Gonçalves, A. Bartsch, R. Deleuze, A. Cortés Salgado, A. Vitorino, M. Tinchon, C. Pecen, L. Rinnerthaler, G. Greil, R.